Embolic Stroke of Undetermined Source Clinical Trial
Official title:
Efficacy and Safety of Cardea SOLOTM for Paroxysmal Atrial Fibrillation Diagnosis in ESUS Patients With Left Atrial Enlargement: Prospective, Multi-center, Open-label, Randomized, Controlled, Investigator-Initiated Trial
The aim of the study is to evaluate the efficacy and safety of the Cardea SOLO Compared to 12 lead EKG for Paroxysmal Atrial Fibrillation Diagnosis in ESUS patients with Left Atrial Enlargement.
The Prospective, Multi-center, Open-label, Randomized, Controlled, Investigator-Initiated Trial will be started on June 2022. Randomized patients in two arms will receive Cardea SOLO or 12 lead EKG respectively. Cardea SOLO received patients will keep it for 7 days. 12 lead EKG received patients will discharge home. After 7 days, Results of Cardea SOLO auto reading will be evaluated by dependent committee including cardiologist. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04455529 -
Current Situation of Natural History, Diagnosis and Treatment in Inpatients With Embolism Stroke of Unknown Cause (ESUS)
|
||
| Completed |
NCT04604015 -
RoBotic TCD Ultrasound BubbLe Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt
|
N/A | |
| Completed |
NCT03107637 -
Transesophageal Echocardiography in Embolic Stroke of Undetermined Source
|
||
| Recruiting |
NCT04808258 -
Embolic Stroke of Undetermined Source, Continuous Electrocardiography and Transthoracic ECHOcardiography in Hospitalized Patients With Ischemic Stroke
|
||
| Completed |
NCT03712865 -
Thirty Day Heart Monitoring for Detection of Atrial Fibrillation Among Cryptogenic Stroke Patients
|
||
| Completed |
NCT03377465 -
Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis
|
N/A | |
| Active, not recruiting |
NCT03329365 -
Paroxysmal Nocturnal Hemoglobinuria in ESUS & ETUS
|
||
| Recruiting |
NCT05089435 -
An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients
|
Phase 4 | |
| Recruiting |
NCT04717843 -
Identification of New Markers of Atrial Myopathy in Patients With Embolic Stroke of Undetermined Source (ESUS) From MRI 4D Data
|
N/A | |
| Enrolling by invitation |
NCT02766205 -
Prediction of AF in ESUS
|
||
| Recruiting |
NCT05238610 -
Prospective Registry of Elderly ESUS With PFO
|
||
| Recruiting |
NCT04898361 -
PFO Occlusion and Atrial Fibrillation
|
N/A | |
| Recruiting |
NCT06100718 -
Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study
|
||
| Recruiting |
NCT05044208 -
Echocardiographic Predictors of Atrial Fibrillation
|
||
| Recruiting |
NCT03820375 -
Registry Study for the Observation of Patients With ESUS/Cryptogenic Stroke
|
||
| Completed |
NCT03609437 -
Impaired Endothelial Integrity in Patients With Embolic Stroke of Undetermined Source (ESUS)
|
||
| Completed |
NCT03185520 -
Young ESUS Patient Registry
|
||
| Completed |
NCT02427126 -
Apixaban for Treatment of Embolic Stroke of Undetermined Source
|
Phase 3 |